BRIEF published on 12/03/2025 at 14:36, 1 day 15 hours ago EUROPLASMA: Statement of voting rights and shares as of November 30, 2025 Voting Rights Financial Markets Financial Transparency Capital Structure Shares In Circulation
BRIEF published on 12/03/2025 at 14:35, 1 day 15 hours ago EUROPLASMA: Publication of voting rights as of November 30, 2025 Share Capital Voting Rights Shares Europlasma November 30, 2025
BRIEF published on 12/02/2025 at 17:50, 2 days 12 hours ago Europlasma: Issue of 200 Bonds Convertible into Shares Convertible Bonds Europlasma Growth Dilution Environmental Performance Financing
BRIEF published on 12/02/2025 at 17:50, 2 days 12 hours ago Europlasma issues 200 bonds for €1 million Convertible Bonds Europlasma Growth Dilutive Financing Investor Risks
BRIEF published on 11/05/2025 at 12:07, 29 days 17 hours ago EUROPLASMA: Capital Status as of October 31, 2025 Share Capital Voting Rights Europlasma Financial Regulations Shares In Circulation
BRIEF published on 10/28/2025 at 07:35, 1 month 7 days ago Availability of the 2025 half-yearly financial report by Europlasma Decarbonization Financial Report Europlasma Dilutive Financing Decontamination
BRIEF published on 10/28/2025 at 07:35, 1 month 7 days ago Europlasma publishes its 2025 half-year financial report Decarbonization Financial Report Funding Europlasma Decontamination
BRIEF published on 10/27/2025 at 18:05, 1 month 8 days ago Europlasma: issue of 200 convertible bonds of €1 million Convertible Bonds Funding Europlasma Dilution Euronext Market
BRIEF published on 10/23/2025 at 18:50, 1 month 12 days ago EUROPLASMA: Results for the First Half of 2025 Financial Results Europlasma Turnover Industries Defense & Railway
BRIEF published on 10/23/2025 at 18:50, 1 month 12 days ago EUROPLASMA: Results for the First Half of 2025 Net Result Europlasma Turnover Industries Asbestos Waste
Published on 12/05/2025 at 02:35, 3 hours 29 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 4 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 59 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 4 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 33 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 13 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 38 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 48 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 53 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 4 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 19 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 19 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 3 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
